Ads
related to: docetaxel taxotere- Common Adverse Reactions
Learn About Managing Potential
Adverse Reactions For ENHERTU®.
- New Approval Info
ENHERTU® Is Now Approved For
a New Indication. Physician Site.
- Efficacy Of ENHERTU®
Learn About The Efficacy
Of ENHERTU® For a New Indication.
- Physician Resources
Access Physician Resources
For ENHERTU® On The Official Site.
- Explore The Data
View More Information On
The Data & Results Of ENHERTU®.
- Prep & Admin
Preparation and Administration
Information For ENHERTU®
- Common Adverse Reactions
Search results
Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Docetaxel Injection, USP Due to...
Tri-County Times· 12 hours agoDocetaxel 80mg per 8mL
Why Is AstraZeneca Stock Trading Lower On Tuesday?
Benzinga via Yahoo Finance· 15 hours ago(NASDAQ:AZN) said the survival results did not reach statistical significance in the overall trial population in the TROPION-Lung01 phase 3 trial....
AstraZeneca and Daiichi Sankyo’s ADC improves survival in NSCLC trial
Clinical Trials Arena via Yahoo Finance· 2 days agoDatopotamab deruxtecan is a trophoblastic cell surface antigen 2 (TROP-2) antibody-drug conjugate....
Candel (CADL) Stock Skyrockets 431% Year to Date: Here's Why
Zacks via Yahoo Finance· 20 hours agoCandel (CADL) surges 431% in the year-to-date period, driven by positive developmental and...
AstraZeneca-Daiichi's Enhertu follow-up Dato-DXd unable to prove overall survival benefit in phase 3
FierceBiotech· 1 day agoDaiichi Sankyo and antibody-drug conjugate (ADC) partner AstraZeneca have already filed their...
Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term...
Digital Journal· 6 days agoPoster highlights durable disease stabilization lasting beyond treatment completionResults suggest a unique, multimodal mechanism of action that differs from other cancer therapeuticsFavorable tolerability sets stage for Part 3 (dose optimization) of
Multi-wall carbon Nanotube surface-based functional nanoparticles for stimuli-responsive dual...
Nature· 2 days agoCarbon nanotubes (CNTs) have the potential to serve as delivery systems for medicinal substances and gene treatments, particularly in cancer treatment. Co-delivery of curcumin (CUR) and Methotrexate ...
Candel (CADL) Reports Upbeat Data From Lung Cancer Study
Zacks via Yahoo Finance· 5 days agoCandel's (CADL) CAN-2409 prolongs overall survival in a phase II study for treating patients with...
AstraZeneca, Daiichi Sankyo's Experimental Lung Cancer Drug Shows Improvement in Patients
Market Watch· 2 days agoAstraZeneca said its experimental drug for non-small cell lung cancer, jointly developed with Japan's Daiichi Sankyo, showed improvement in progression-free survival in its latest trial, moving ...
